Source: Eur Respir J 2010; 35: 927-929



Rating:

Share or cite this content

Citations should be made in the following way:
Sandhu G., Dasgupta R., Ranade A., Baskin M.. Pneumocystis pneumonia in an HIV-negative patient with no overt risk factors on presentation. Eur Respir J 2010; 35: 927-929

Member's Comments

No comment yet.

Related content which might interest you: Clinical prognostic factors for pneumocystis pneumonia in non-HIV patients Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Clinical outcome and prognostic factors of acute respiratory failure due to pneumocystis pneumonia in non-HIV patients Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients Source: Eur Respir J 2001; 17: 87-93 Year: 2001 Clinical manifestations and a prognostic factor of pneumocystis pneumonia without HIV infection Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011 Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with Pneumocystis pneumonia Source: ERJ Open Res, 6 (2) 00306-2019; 10.1183/23120541.00306-2019 Year: 2020 Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018 Early recurrence of pneumocystis jiroveci pneumonia (PCP) in two HIV-infected patients: linking infection relapse and immune reconstitution syndrome Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007 The main risk factors of the community-acquired pneumonia delayed course Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Risk factors for fatal tuberculosis among immunocompetent patients. Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 Incidence, risk factors and outcomes of nonresolving pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Clinical patterns of Pneumocystis Jirovecii in HIV and non-HIV patients Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 The influence of chronic concomitant diseases and age on the risk of death in patients with community-aquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002 Risk factors of nosocomial pneumonia in multiple trauma patients Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007 Treatment failure of community-acquired pneumonia: risk factors and consequences Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012 Recurrent pneumonia in a patient with HIV Source: International Congress 2018 – CC8 Non-resolving pneumonia Year: 2018 Usefulness of alveoloscopy in the diagnosis pf Pneumocystis jiroveci pneumonia in HIV+ patients Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Pneumocystis jiroveci colonisation in Turkish patients with primary pulmonary disorders Source: Eur Respir J 2005; 26: Suppl. 49, 411s Year: 2005 Risk factors for early onset severe community-acquired pneumonia complications Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018